• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低免疫原性单域抗体变体的设计与合成

Design and Synthesis of Monobody Variants with Low Immunogenicity.

作者信息

Iwamoto Naoya, Sato Yukino, Manabe Asako, Inuki Shinsuke, Ohno Hiroaki, Nonaka Motohiro, Oishi Shinya

机构信息

Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.

Laboratory of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.

出版信息

ACS Med Chem Lett. 2023 Oct 9;14(11):1596-1601. doi: 10.1021/acsmedchemlett.3c00342. eCollection 2023 Nov 9.

DOI:10.1021/acsmedchemlett.3c00342
PMID:37974939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10641909/
Abstract

Mirror-image proteins (d-proteins) are promising scaffolds for drug discovery because of their high proteolytic stability and low immunogenic properties. Facile and reproducible processes for the preparation of functional d-proteins are required for their application in therapeutic biologics. In this study, we designed and synthesized a novel monobody variant with two cysteine substitutions that facilitate the synthetic process via sequential native chemical ligations and improve protein stability by disulfide bond formation. The synthetic anti-GFP monobody in this model study exhibited good binding affinity to the target enhanced green fluorescent protein. In vivo administration of the synthetic anti-GFP monobody (l-monobody) to mice induced antidrug antibody (ADA) production, whereas no ADA production was observed following immunization with the mirror-image anti-GFP monobody (d-monobody). These results suggest that the synthetic d-monobody is a non-antibody protein scaffold with low immunogenic properties.

摘要

镜像蛋白(D-蛋白)因其高蛋白水解稳定性和低免疫原性,是药物研发中很有前景的支架。功能性D-蛋白的制备需要简便且可重复的过程,以便其应用于治疗性生物制品。在本研究中,我们设计并合成了一种新型单域抗体变体,其具有两个半胱氨酸取代,可通过顺序天然化学连接促进合成过程,并通过形成二硫键提高蛋白质稳定性。该模型研究中的合成抗绿色荧光蛋白单域抗体对目标增强型绿色荧光蛋白表现出良好的结合亲和力。向小鼠体内注射合成抗绿色荧光蛋白单域抗体(L-单域抗体)会诱导抗药物抗体(ADA)产生,而用镜像抗绿色荧光蛋白单域抗体(D-单域抗体)免疫后未观察到ADA产生。这些结果表明,合成的D-单域抗体是一种具有低免疫原性的非抗体蛋白支架。

相似文献

1
Design and Synthesis of Monobody Variants with Low Immunogenicity.低免疫原性单域抗体变体的设计与合成
ACS Med Chem Lett. 2023 Oct 9;14(11):1596-1601. doi: 10.1021/acsmedchemlett.3c00342. eCollection 2023 Nov 9.
2
Mirror-Image Single-Domain Antibody for a Novel Nonimmunogenic Drug Scaffold.镜像单域抗体用于新型非免疫原性药物支架。
Bioconjug Chem. 2023 Nov 15;34(11):2055-2065. doi: 10.1021/acs.bioconjchem.3c00372. Epub 2023 Oct 26.
3
Mutational and biophysical robustness in a prestabilized monobody.在预先稳定的单域抗体中实现突变和生物物理稳健性。
J Biol Chem. 2021 Jan-Jun;296:100447. doi: 10.1016/j.jbc.2021.100447. Epub 2021 Feb 20.
4
Engineering a Low-Immunogenic Mirror-Image VHH against Vascular Endothelial Growth Factor.工程化一种低免疫原性的血管内皮生长因子镜像 VH。
ACS Chem Biol. 2024 May 17;19(5):1194-1205. doi: 10.1021/acschembio.4c00197. Epub 2024 May 2.
5
Engineering of an EPHA2-Targeted Monobody for the Detection of Colorectal Cancer.工程化靶向 EphA2 的单域抗体用于结直肠癌的检测。
Cancer Genomics Proteomics. 2024 May-Jun;21(3):285-294. doi: 10.21873/cgp.20447.
6
Mechanism of single- and double-sided inhibition of dual topology fluoride channels by synthetic monobodies.合成单域抗体对双拓扑氟离子通道的单侧和双侧抑制机制
J Gen Physiol. 2017 Apr 3;149(4):511-522. doi: 10.1085/jgp.201611747. Epub 2017 Mar 3.
7
Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling.利用细菌 III 型分泌系统将单域抗体递送至细胞质中可抑制致癌 BCR:ABL1 信号。
Cell Commun Signal. 2024 Oct 16;22(1):500. doi: 10.1186/s12964-024-01874-6.
8
Monobodies as tool biologics for accelerating target validation and druggable site discovery.单克隆抗体作为加速靶点验证和可成药位点发现的工具性生物制剂。
RSC Med Chem. 2021 Sep 13;12(11):1839-1853. doi: 10.1039/d1md00188d. eCollection 2021 Nov 17.
9
Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.探索 KRAS(G12D)的变构开关 II 口袋构象与突变体选择性单域抗体抑制剂。
Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2302485120. doi: 10.1073/pnas.2302485120. Epub 2023 Jul 3.
10
Modular Nanotransporters Capable of Binding to SARS-CoV-2 Virus Nucleocapsid Protein in Target Cells.能够与靶细胞中 SARS-CoV-2 病毒核衣壳蛋白结合的模块化纳米转运体。
Dokl Biochem Biophys. 2023 Jun;510(1):87-90. doi: 10.1134/S1607672922600233. Epub 2023 Aug 15.

引用本文的文献

1
Heat-sterilizable antibody mimics designed on the cold shock protein scaffold from hyperthermophile Thermotoga maritima.基于嗜热栖热袍菌冷休克蛋白支架设计的可热灭菌抗体模拟物。
Protein Sci. 2025 Jan;34(1):e70018. doi: 10.1002/pro.70018.
2
Generating a mirror-image monobody targeting MCP-1 via TRAP display and chemical protein synthesis.通过TRAP展示和化学蛋白质合成生成靶向单核细胞趋化蛋白-1(MCP-1)的镜像单域抗体。
Nat Commun. 2024 Dec 23;15(1):10723. doi: 10.1038/s41467-024-54902-x.
3
Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase.靶向致癌性BCR::ABL1激酶的镜像单链抗体的研发。
Nat Commun. 2024 Dec 23;15(1):10724. doi: 10.1038/s41467-024-54901-y.

本文引用的文献

1
D-Peptide and D-Protein Technology: Recent Advances, Challenges, and Opportunities.D-肽和 D-蛋白技术:最新进展、挑战与机遇。
Chembiochem. 2023 Feb 14;24(4):e202200537. doi: 10.1002/cbic.202200537. Epub 2022 Nov 16.
2
Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.使用镜像噬菌体展示技术针对 Tau 重复 2 筛选出的强效 Tau 聚集抑制剂 D-肽。
Chembiochem. 2021 Nov 3;22(21):3049-3059. doi: 10.1002/cbic.202100287. Epub 2021 Sep 12.
3
A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth.一种无免疫原性的二价 d 蛋白可有效抑制视网膜血管生成和肿瘤生长。
ACS Chem Biol. 2021 Mar 19;16(3):548-556. doi: 10.1021/acschembio.1c00017. Epub 2021 Feb 23.
4
Chemical Protein Synthesis in Medicinal Chemistry.化学蛋白质合成在药物化学中的应用。
J Med Chem. 2020 Dec 24;63(24):15140-15152. doi: 10.1021/acs.jmedchem.0c01082. Epub 2020 Nov 25.
5
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies.单克隆抗体治疗后形成抗药物抗体的免疫生物学的分子机制。
Front Immunol. 2020 Aug 18;11:1951. doi: 10.3389/fimmu.2020.01951. eCollection 2020.
6
A Novel d-Peptide Identified by Mirror-Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy.一种新型 d-肽通过镜像噬菌体展示技术鉴定,可阻断 TIGIT/PVR 用于癌症免疫治疗。
Angew Chem Int Ed Engl. 2020 Aug 24;59(35):15114-15118. doi: 10.1002/anie.202002783. Epub 2020 Jun 8.
7
Monobodies as enabling tools for structural and mechanistic biology.单域抗体作为结构和机制生物学的使能工具。
Curr Opin Struct Biol. 2020 Feb;60:167-174. doi: 10.1016/j.sbi.2020.01.015. Epub 2020 Mar 4.
8
Engineered Protein Scaffolds as Next-Generation Therapeutics.工程化蛋白质支架作为下一代治疗药物。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:391-415. doi: 10.1146/annurev-pharmtox-010818-021118.
9
Development of Mirror-Image Screening Systems for XIAP BIR3 Domain Inhibitors.开发 XIAP BIR3 结构域抑制剂的镜像筛选系统。
Bioconjug Chem. 2019 May 15;30(5):1395-1404. doi: 10.1021/acs.bioconjchem.9b00154. Epub 2019 Apr 17.
10
Advances in Native Chemical Ligation-Desulfurization: A Powerful Strategy for Peptide and Protein Synthesis.Native Chemical Ligation-Desulfurization 的进展:一种用于肽和蛋白质合成的强大策略。
Chemistry. 2018 Nov 27;24(66):17397-17404. doi: 10.1002/chem.201802067. Epub 2018 Oct 8.